Pancreatic Cancer: BRCA Targeted Therapy and Beyond

SIMPLE SUMMARY: Pancreatic cancer is associated with poor outcomes for several reasons, including diagnosis at an advanced stage, the absence of effective screening for the diagnosis, and resistance to treatments. Pancreatic cancers associated with BRCA1/2 mutations have emerged as a distinct subgro...

Descripción completa

Detalles Bibliográficos
Autores principales: Keane, Fergus, O’Connor, Catherine A., Park, Wungki, Seufferlein, Thomas, O’Reilly, Eileen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251879/
https://www.ncbi.nlm.nih.gov/pubmed/37296917
http://dx.doi.org/10.3390/cancers15112955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251879/
https://www.ncbi.nlm.nih.gov/pubmed/37296917
http://dx.doi.org/10.3390/cancers15112955

Ejemplares similares